Showing results (71-80 of 759) with videos related to
Sort By:
Pageof 76
Advances in Experimental Medicine and Biology|April 29, 2008
Targeting proteasomes as therapy in multiple myelomaDharminder Chauhan, Teru Hideshima, Kenneth C AndersonExperimental Hematology|June 30, 2015
Novel therapeutic strategies for multiple myelomaNaoya Mimura, Teru Hideshima, Kenneth C AndersonImmunological Reviews|July 9, 2003
Novel therapeutic approaches for multiple myelomaTeru Hideshima, Paul Richardson, Kenneth C AndersonInternational Journal of Hematology|September 5, 2003
Apoptotic signaling in multiple myeloma: therapeutic implicationsDharminder Chauhan, Teru Hideshima, Kenneth C AndersonAnnual Review of Pharmacology and Toxicology|April 12, 2005
Proteasome inhibition in multiple myeloma: therapeutic implicationDharminder Chauhan, Teru Hideshima, Kenneth C AndersonMolecular & Cellular Oncology|June 17, 2016
Awakening the Hippo co-activator YAP1, a mercurial cancer gene, in hematologic cancersFrancesca Cottini, Kenneth C Anderson, Giovanni TononBlood Reviews|December 4, 2010
Multiple myeloma: biology of the diseaseAnuj Mahindra, Teru Hideshima, Kenneth C AndersonInternational Journal of Hematology|April 22, 2016
Histone deacetylase inhibitors in multiple myeloma: from bench to bedsideTakeshi Harada, Teru Hideshima, Kenneth C AndersonBMC Biochemistry|November 26, 2008
Targeting the UPS as therapy in multiple myelomaDharminder Chauhan, Giada Bianchi, Kenneth C AndersonBlood Cancer Journal|September 8, 2018
The biological significance of histone modifiers in multiple myeloma: clinical applicationsHiroto Ohguchi, Teru Hideshima, Kenneth C AndersonPageof 76